Recent Updates
Recently added Catalysts
GRDN Positive Sentiment

Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Guardian Pharmacy Services reported its third quarter financial results for 2026, revealing a revenue of $371.1 million, which reflects a 2% decrease due to pricing changes from the IRA. The company served approximately 218,000 residents, marking a 7% increase year-over-year. Additionally, Guardian raised its full-year guidance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue reached $371.1 million.
  • Residents served increased by 7% year-over-year.
  • Full-year guidance was raised.

Full Press Release Details

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2026. The Company also raised its full-year guidance. Third Quarter Financial Results Residents served ended the quarter at approximately 218,000, up 7% year-over-year. Reported Revenue of $371.1 million, inclusive of pricing decreases as a result of the IRA, down 2

Frequently Asked Questions

What were Guardian's Q3 2026 revenues?

Guardian reported third-quarter revenue of $371.1 million, which included pricing decreases resulting from the Inflation Reduction Act.

How many residents did Guardian serve in Q3?

The company served approximately 218,000 residents during the third quarter, marking a 7% increase compared to the prior year period.

Did Guardian raise its full-year guidance?

Yes, Guardian Pharmacy Services announced that it raised its full-year guidance alongside the release of its third-quarter financial results.

What was the year-over-year growth in residents?

Resident volume grew by 7% year-over-year, reaching approximately 218,000 residents served by the end of the third quarter.

ShareAdd on Google
Tags: GRDN Guardian Pharmacy Services financial results long-term care pharmacy revenue
Last updated: Nov 5, 2026

Biotech snapshot

Cash runway
$90M liquidity · $0M/mo burn
Low dilution risk